LECT2 and metabolic syndrome: Because it has been confirmed that activation of liver AMPK enhances fatty acid oxidation and inhibits triglycerides and cholesterol synthesis [32], LECT2 may play a role in visceral fat-induced inactivation of liver AMPK, and therefore be associated with dyslipidemia.